The Accountable Care Organisation is the most ambiguous of the new entities borne of the Affordable Care Act – however, an understanding of the principles of engagement with this trailblazing new institution is crucial to successful navigation of the US oncology landscape.
We’ve commissioned this paper in order to give you a clear pathway to successful collaboration with America’s biggest and most innovative ACOs.
Contributing to the paper are:
Ira Klein, National Medical Director, Clinical Thought Leadership, Office of the CMO, AETNA
Howard Buff, CEO, Orange Health
Byran Litton, Senior Director, Oncology Payer and Strategy, Eli Lilly
Matt Farber, Director, Provider Economics and Public Policy, Association of Community Cancer Centers
John Venetos, M.D. CEO of Independent Physician’s ACO of Chicago (IPACO)
Mark Hillard, CEO of Arizona Care Network
By downloading the paper, you’ll receive expert insights and proven strategies for ACO engagement, covering:
How oncology pharma can succeed in the new ACO paradigm
Tried-and-tested pathways to intelligent engagement and collaboration with Accountable Care ORganisations
How pharma can develop an integrated system and manage quality data for guaranteed outcomes
The long term ramifications of aligning payment incentives around the consumer
More information available here.